PMID- 33432690 OWN - NLM STAT- MEDLINE DCOM- 20211210 LR - 20211214 IS - 1462-5822 (Electronic) IS - 1462-5814 (Linking) VI - 23 IP - 4 DP - 2021 Apr TI - Valosin-containing protein ATPase activity regulates the morphogenesis of Zika virus replication organelles and virus-induced cell death. PG - e13302 LID - 10.1111/cmi.13302 [doi] AB - With no available therapies, infections with Zika virus (ZIKV) constitute a major public health concern as they can lead to congenital microcephaly. In order to generate an intracellular environment favourable to viral replication, ZIKV induces endomembrane remodelling and the morphogenesis of replication factories via enigmatic mechanisms. In this study, we identified the AAA+ type ATPase valosin-containing protein (VCP) as a cellular interaction partner of ZIKV non-structural protein 4B (NS4B). Importantly, its pharmacological inhibition as well as the expression of a VCP dominant-negative mutant impaired ZIKV replication. In infected cells, VCP is relocalised to large ultrastructures containing both NS4B and NS3, which are reminiscent of dengue virus convoluted membranes. Moreover, short treatment with the VCP inhibitors NMS-873 or CB-5083 drastically decreased the abundance and size of ZIKV-induced convoluted membranes. Furthermore, NMS-873 treatment inhibited ZIKV-induced mitochondria elongation previously reported to be physically and functionally linked to convoluted membranes in case of the closely related dengue virus. Finally, VCP inhibition resulted in enhanced apoptosis of ZIKV-infected cells strongly suggesting that convoluted membranes limit virus-induced cytopathic effects. Altogether, this study identifies VCP as a host factor required for ZIKV life cycle and more precisely, for the maintenance of viral replication factories. Our data further support a model in which convoluted membranes regulate ZIKV life cycle by impacting on mitochondrial functions and ZIKV-induced death signals in order to create a cytoplasmic environment favourable to viral replication. CI - (c) 2021 John Wiley & Sons Ltd. FAU - Anton, Anais AU - Anton A AD - Centre Armand-Frappier Sante Biotechnologie, Institut National de la Recherche Scientifique, Laval, Quebec, Canada. FAU - Mazeaud, Clement AU - Mazeaud C AD - Centre Armand-Frappier Sante Biotechnologie, Institut National de la Recherche Scientifique, Laval, Quebec, Canada. FAU - Freppel, Wesley AU - Freppel W AUID- ORCID: 0000-0003-3628-0465 AD - Centre Armand-Frappier Sante Biotechnologie, Institut National de la Recherche Scientifique, Laval, Quebec, Canada. FAU - Gilbert, Claudia AU - Gilbert C AD - Centre Armand-Frappier Sante Biotechnologie, Institut National de la Recherche Scientifique, Laval, Quebec, Canada. FAU - Tremblay, Nicolas AU - Tremblay N AUID- ORCID: 0000-0003-4246-7189 AD - Centre Armand-Frappier Sante Biotechnologie, Institut National de la Recherche Scientifique, Laval, Quebec, Canada. FAU - Sow, Aissatou Aicha AU - Sow AA AD - Centre Armand-Frappier Sante Biotechnologie, Institut National de la Recherche Scientifique, Laval, Quebec, Canada. FAU - Roy, Marie AU - Roy M AD - Centre Armand-Frappier Sante Biotechnologie, Institut National de la Recherche Scientifique, Laval, Quebec, Canada. FAU - Rodrigue-Gervais, Ian Gael AU - Rodrigue-Gervais IG AD - Centre Armand-Frappier Sante Biotechnologie, Institut National de la Recherche Scientifique, Laval, Quebec, Canada. FAU - Chatel-Chaix, Laurent AU - Chatel-Chaix L AUID- ORCID: 0000-0002-7390-8250 AD - Centre Armand-Frappier Sante Biotechnologie, Institut National de la Recherche Scientifique, Laval, Quebec, Canada. AD - Center of Excellence in Research on Orphan Diseases-Courtois Foundation (CERMO-FC), Montreal, Quebec, Canada. AD - Reseau Intersectoriel de Recherche en Sante de l'Universite du Quebec (RISUQ), Quebec, Canada. LA - eng GR - ICS154142/CIHR/Canada GR - ICS154142/CIHR/Canada GR - PJT153020/CIHR/Canada PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20210111 PL - India TA - Cell Microbiol JT - Cellular microbiology JID - 100883691 RN - 0 (Acetanilides) RN - 0 (Benzothiazoles) RN - 0 (CB-5083) RN - 0 (Indoles) RN - 0 (NMS-873) RN - 0 (Pyrimidines) RN - EC 3.6.1.- (Adenosine Triphosphatases) RN - EC 3.6.4.6 (Valosin Containing Protein) SB - IM MH - Acetanilides/pharmacology MH - Adenosine Triphosphatases/genetics/*metabolism MH - Animals MH - *Apoptosis MH - Benzothiazoles/pharmacology MH - Cell Line, Tumor MH - Chlorocebus aethiops MH - *Gene Expression Regulation MH - HEK293 Cells MH - Host Microbial Interactions/drug effects/genetics MH - Humans MH - Indoles/pharmacology MH - Mitochondria/drug effects/metabolism/virology MH - Pyrimidines/pharmacology MH - Valosin Containing Protein/antagonists & inhibitors/*genetics/*metabolism MH - Vero Cells MH - Zika Virus/*genetics/*physiology EDAT- 2021/01/13 06:00 MHDA- 2021/12/15 06:00 CRDT- 2021/01/12 06:15 PHST- 2020/03/01 00:00 [received] PHST- 2020/12/01 00:00 [revised] PHST- 2020/12/15 00:00 [accepted] PHST- 2021/01/13 06:00 [pubmed] PHST- 2021/12/15 06:00 [medline] PHST- 2021/01/12 06:15 [entrez] AID - 10.1111/cmi.13302 [doi] PST - ppublish SO - Cell Microbiol. 2021 Apr;23(4):e13302. doi: 10.1111/cmi.13302. Epub 2021 Jan 11.